CN105213262A - A kind of NO/cGMP protease cell neogenesis stock solution and preparation method thereof - Google Patents

A kind of NO/cGMP protease cell neogenesis stock solution and preparation method thereof Download PDF

Info

Publication number
CN105213262A
CN105213262A CN201510713646.9A CN201510713646A CN105213262A CN 105213262 A CN105213262 A CN 105213262A CN 201510713646 A CN201510713646 A CN 201510713646A CN 105213262 A CN105213262 A CN 105213262A
Authority
CN
China
Prior art keywords
cgmp
stock solution
extract
skin
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510713646.9A
Other languages
Chinese (zh)
Inventor
苏建华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510713646.9A priority Critical patent/CN105213262A/en
Publication of CN105213262A publication Critical patent/CN105213262A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Abstract

The present invention relates to a kind of NO/cGMP protease cell neogenesis stock solution, it is characterized in that, it comprises containing following component by percentage to the quality: Herba portulacae extract 1-6%, camomile extract 2-6%, aloe vera extract 1-3%, Radix Astragali extract 1-2%, hydrolysis avenin 0.5-2%, hyaluronate sodium 5-10%, hydrogenated polydecene 3-5%, wetting agent 10-20%, pH adjusting agent 0.1-3%, antiseptic 0.1-1%, excess water.Above-mentioned active substance is carried out reasonable compatibility by the present invention, by the protease that above-mentioned active substance produces, activate the NO in dermis of skin confluent monolayer cells, synthesis cGMP, kills the long pox cell in pilosebaceous unit, the secretion of balance hair follicle sebocyte cell, and then by repairing and promoting that Skin Cell regenerates, recover skin health, reach radical cure acne, repair Acne Scar, recover object that is delicate and smooth healthy skin.

Description

A kind of NO/cGMP protease cell neogenesis stock solution and preparation method thereof
Technical field
The present invention relates to cosmetic technical field, be specifically related to a kind of NO/cGMP protease cell neogenesis stock solution.
Background technology
At present, the raising gradually of living standard, along with the growth at age and the increase of life and work pressure, skin senesces gradually, and the skin problem such as drying, microgroove, dim mute, melanin deposition comes one after another.Acne is also known as comedo, and acne and skin sore, infect primarily of anaerobic propionibacterium acnes and cause, belong to pilosebaceous chronic dermatosis, in the treatment of comedo and acne, mainly use antibiotic traditionally.Although the comedo for the treatment of method to general or local has certain curative effect, life-time service can make bacterial resistance occurred.1993, the research of Britain 400 many cases acne patient is being shown have 40% to show Drug resistance to one or more antibacterial in these patients.Although also there are some acne-eliminating cosmetics, rebound rate is higher.
Summary of the invention
The object of the invention is to the defect overcoming prior art, there is provided a kind of and promote hair follicle sebum glandular secretion balance, antiinflammatory and injury repairing, promote the cellular-restoring secretion balance in sebaceous gland simultaneously, thus the NO/cGMP protease cell neogenesis stock solution of radical cure acne, provide its preparation method simultaneously.
To achieve these goals, the technical scheme taked of the present invention is as follows:
Technical scheme one:
A kind of NO/cGMP protease cell neogenesis stock solution, it comprises containing following component by percentage to the quality:
Further improve as the present invention, it comprises containing following component by percentage to the quality:
Further improve as the present invention, described wetting agent be selected from glycerol, propylene glycol and butanediol one or more.
Further improve as the present invention, described antiseptic be selected from phenoxyethanol, methyl hydroxybenzoate, ethyl hydroxybenzoate, propyl hydroxybenzoate, sorbic acid, benzoic acid one or more.
Further improve as the present invention, described pH adjusting agent be selected from triethanolamine, arginine or amino-propanediol one or more.
Technical scheme two:
A preparation method for essence is repaired by a kind of described cell regeneration unit of technical scheme, specifically comprises the following steps:
With water, hydrogenated polydecene is disperseed, be warming up to 90-100 DEG C, add wetting agent and stir 10-15min, be cooled to 35-45 DEG C, add Herba portulacae extract, camomile extract, aloe vera extract, Radix Astragali extract, hydrolysis avenin, hyaluronate sodium, PH regulator and antiseptic, stir, be down to room temperature, obtain product.
Compared with prior art, the beneficial effect acquired by the present invention is as follows:
Herba portulacae extract in the present invention also claims Herba Angelicae Keiskei in China, is rich in the compounds such as a large amount of flavonoids, adrenin, polysaccharide and various vitamin, aminoacid wherein.In cosmetics: the various stimulations being mainly used in antiallergic, antiinflammatory antiinflammatory and anti-outer bound pair skin, acne-removal function in addition.Obvious anti-allergic effects is had especially to the skin allergy that life-time service hormones cosmetics produce.
Camomile extract in the present invention can suppress inflammation, healing of wound, and it has the effect of sterilizing, maintenance laceration of skin; Be used in maintenance, moisturizing can be had, the calm skin restrain pore of releiving; Add that there is refrigerant, to help skin tissue regeneration effect.
Containing glucose, mannose, alduronic acid, calcium, hydrated protein enzyme, bio-hormone, hormone, protein, aminoacid, vitamin, mineral and other trace element in aloe vera extract in the present invention, therefore there is nourishing and moisturizing, sun-proof, effect such as Hang Yan, hair-dressing and hair care, meanwhile, it to softening skin, restrain, prevent and treat acne, prevent pachylosis, anti-inflammatory anti-itch, hair care, the delicate Bai Jie of maintenance skin etc. have remarkable efficacy.Aloe has good compatibility, can coordinate well, and can eliminate the injury of kinds of surface activating agent to skin with the brilliant raw material of various cosmetic.
Radix Astragali extract in the present invention possesses invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, the effect of expelling pus and promoting granulation, and Radix Astragali saponin can activate cells in vivo NO-cGMP system.
Hyaluronate sodium in the present invention can stop the generation of some enzymes in cell, reduce the formation of free radical, destroy cellularity preventing free radical, produce lipid peroxidation and cause the important roles such as senility of humanbody: low-molecular-weight hyaluronic acid has antiinflammatory, suppresses pathogenic bacteria to produce, keeps the effect that skin is bright and clean; For cell proliferation and differentiation provide suitable place, direct Promote cell's growth, differentiation, reconstruction and reparation etc.
Hydrolysis avenin in the present invention and " cytokine " in skin closely similar, after percutaneous absorption, the generation of new cell can be improved, new cell is emerged in large numbers, promote skin metabolism.
Above-mentioned active substance is carried out reasonable compatibility by the present invention, by the protease that above-mentioned active substance produces, activate the NO (nitric oxide) in dermis of skin confluent monolayer cells, synthesis cGMP (cyclic guanosine monophosphate), kills the long pox cell in pilosebaceous unit, the secretion of balance hair follicle sebocyte cell, and then by repairing and promoting that Skin Cell regenerates, recover skin health, reach radical cure acne, repair Acne Scar, recover object that is delicate and smooth healthy skin.
Detailed description of the invention
Below in conjunction with specific embodiment, detailed further describing is carried out to the present invention.
Embodiment 1
A kind of NO/cGMP protease cell neogenesis stock solution, it comprises containing following component by percentage to the quality:
With water, hydrogenated polydecene is disperseed, be warming up to 90-100 DEG C, add glycerol and propylene glycol stirring 10-15min, be cooled to 35-45 DEG C, add Herba portulacae extract, camomile extract, aloe vera extract, Radix Astragali extract, hydrolysis avenin, hyaluronate sodium, triethanolamine and methyl hydroxybenzoate, stir, be down to room temperature, obtain product.
Embodiment 2
A kind of NO/cGMP protease cell neogenesis stock solution, it comprises containing following component by percentage to the quality:
With water, hydrogenated polydecene is disperseed, be warming up to 90-100 DEG C, add glycerol and stir 10-15min, be cooled to 35-45 DEG C, add Herba portulacae extract, camomile extract, aloe vera extract, Radix Astragali extract, hydrolysis avenin, hyaluronate sodium, arginine and phenoxyethanol, stir, be down to room temperature, obtain product.
Embodiment 3
A kind of NO/cGMP protease cell neogenesis stock solution, it comprises containing following component by percentage to the quality:
With water, hydrogenated polydecene is disperseed, be warming up to 90-100 DEG C, add propylene glycol and stir 10-15min, be cooled to 35-45 DEG C, add Herba portulacae extract, camomile extract, aloe vera extract, Radix Astragali extract, hydrolysis avenin, hyaluronate sodium, triethanolamine and ethyl hydroxybenzoate, stir, be down to room temperature, obtain product.
Effect example:
Choose 100 volunteers, 13 years old ~ 38 years old age, average 23 years old, each 50 of men and women.All there are pimple, pustule, pockmark in face.
Using method: after clean, gets appropriate embodiment 1 and prepares sample and spread upon affected part, be massaged into gently and absorb completely, and twice daily, using for 1 course for the treatment of continuously, 4 weeks is a course for the treatment of.
Curative effect: skin lesion counting × 100% before curative effect=(before treatment the rear skin lesion counting of skin lesion counting-treatment)/treatment
Effective: skin lesion disappears 60% ~ 90%, and symptom alleviates;
Effective: skin lesion disappears 20% ~ 60%, symptom is improved;
Invalid: skin lesion disappears < 20%, and clinical symptoms is not improved;
Result: effective percentage is 93%.
The above embodiment is only the preferred embodiments of the present invention, and and the feasible enforcement of non-invention exhaustive.For persons skilled in the art, to any apparent change done by it under the prerequisite not deviating from the principle of the invention and spirit, all should be contemplated as falling with within claims of the present invention.

Claims (6)

1. a NO/cGMP protease cell neogenesis stock solution, is characterized in that, it comprises containing following component by percentage to the quality:
2. a kind of NO/cGMP protease cell neogenesis stock solution according to claim 1, is characterized in that, it comprises containing following component by percentage to the quality:
3. a kind of NO/cGMP protease cell neogenesis stock solution according to claim 1, is characterized in that, described wetting agent be selected from glycerol, propylene glycol and butanediol one or more.
4. a kind of NO/cGMP protease cell neogenesis stock solution according to claim 1, is characterized in that, described antiseptic be selected from phenoxyethanol, methyl hydroxybenzoate, ethyl hydroxybenzoate, propyl hydroxybenzoate, sorbic acid, benzoic acid one or more.
5. a kind of NO/cGMP protease cell neogenesis stock solution according to claim 1, is characterized in that, described pH adjusting agent be selected from triethanolamine, arginine or amino-propanediol one or more.
6. a preparation method for the NO/cGMP protease cell neogenesis stock solution as described in any one of claim 1-5, is characterized in that, specifically comprise the following steps:
With water, hydrogenated polydecene is disperseed, be warming up to 90-100 DEG C, add wetting agent and stir 10-15min, be cooled to 35-45 DEG C, add Herba portulacae extract, camomile extract, aloe vera extract, Radix Astragali extract, hydrolysis avenin, hyaluronate sodium, PH regulator and antiseptic, stir, be down to room temperature, obtain product.
CN201510713646.9A 2015-10-29 2015-10-29 A kind of NO/cGMP protease cell neogenesis stock solution and preparation method thereof Pending CN105213262A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510713646.9A CN105213262A (en) 2015-10-29 2015-10-29 A kind of NO/cGMP protease cell neogenesis stock solution and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510713646.9A CN105213262A (en) 2015-10-29 2015-10-29 A kind of NO/cGMP protease cell neogenesis stock solution and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105213262A true CN105213262A (en) 2016-01-06

Family

ID=54982788

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510713646.9A Pending CN105213262A (en) 2015-10-29 2015-10-29 A kind of NO/cGMP protease cell neogenesis stock solution and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105213262A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105662948A (en) * 2016-01-20 2016-06-15 北京莱伊莲生物科技有限责任公司 Low-irritation nicotinamide composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102101880A (en) * 2009-12-17 2011-06-22 北京大学 Preparation method and application of radix astragali saponin
CN103271855A (en) * 2013-05-23 2013-09-04 苏州谷力生物科技有限公司 Skincare water for removing acnes and preparation method thereof
CN103751081A (en) * 2014-01-26 2014-04-30 广东景兴卫生用品有限公司 Natural anti-acne conditioner and preparation process thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102101880A (en) * 2009-12-17 2011-06-22 北京大学 Preparation method and application of radix astragali saponin
CN103271855A (en) * 2013-05-23 2013-09-04 苏州谷力生物科技有限公司 Skincare water for removing acnes and preparation method thereof
CN103751081A (en) * 2014-01-26 2014-04-30 广东景兴卫生用品有限公司 Natural anti-acne conditioner and preparation process thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105662948A (en) * 2016-01-20 2016-06-15 北京莱伊莲生物科技有限责任公司 Low-irritation nicotinamide composition
CN105662948B (en) * 2016-01-20 2018-03-09 北京莱伊莲生物科技有限责任公司 The nicotinoyl amine composition of low irritant

Similar Documents

Publication Publication Date Title
CN105769654B (en) A kind of Shu Min skin care compositions and its application in cosmetics
CN104667335A (en) Recombinant human-derived collagen product for skin barrier function or haemorrhoids and preparation method
CN105193672B (en) A kind of cytothesis member repairs Essence and preparation method thereof
Kuo et al. Plectranthus amboinicus and Centella asiatica cream for the treatment of diabetic foot ulcers
CN104644523A (en) Medical biological wrinkle-removing and speckle-inhibiting dressing and preparation method thereof
CN106822988A (en) Alginate fibre functional dressing and its application, alginate fibre functional dressing patch
CN104434768A (en) Moisturizing lotion with slow-release efficacy and preparation method of moisturizing lotion
EA032439B1 (en) Compositions and methods for treating surface wounds
CN105536027A (en) Scar treatment strip capable of lowering tissue tension and preparation method thereof
CN108653129B (en) Skin dressing containing natural plant anti-allergy composition
CN108743921A (en) It is a kind of to prevent the reparation liquid and its preparation method and application that scar is formed
KR102249700B1 (en) Comsmetic composition comprising mint vinegar
CN103494877A (en) Composition for treating scar and preparation method thereof
CN112206176A (en) Bath cream for daily maintenance of psoriasis and seborrheic dermatitis skin
CN106333880B (en) toner based on thin emulsion and preparation method thereof
US20170281690A1 (en) Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis
CN108078868B (en) Antiallergic composition for skin care products
CN105213262A (en) A kind of NO/cGMP protease cell neogenesis stock solution and preparation method thereof
CN103520708A (en) Composition capable of promoting wound healing and reducing scarring
CN109662939A (en) A kind of newborn composition of chest enlarge U.S., chest enlarge breast cream and preparation method thereof
CN105497537A (en) Medicine composition with skin whitening and tendering functions and preparing method thereof
CN109330947A (en) A kind of oil control and acne removal toner and preparation method thereof
CN107551090A (en) One kind, which is nourished, repairs gel
CN102697835A (en) External medicament for treating skin diseases
KR20120140450A (en) Composition for promoting the differentiation of human mesenchymal stem cell

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160106

RJ01 Rejection of invention patent application after publication